BioSpace News Archive

Received Positive Response from FDA Regarding IV Meloxicam Formal Dispute Resolution Request

Concert Pharmaceuticals, Inc. announced that it will report its third quarter 2019 financial results on Thursday, November 7, 2019, before the U.S. financial markets open.

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, issued the following letter to shareholders.

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the presentation of results from a study validating a newly developed nomogram tool that combines information from the DecisionDx®-Melanoma test with clinicopathologic features to improve prediction of patients’ risk of melanoma recurrence.

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, reported financial results for the quarter ended 30 September 2019 and provided an update on its clinical activities.

International medical imaging IT and cybersecurity company Sectra has signed a five-year contract for its enterprise imaging solution with the Dutch University Medical Center Groningen With the solution, image handling across the hospital will be consolidated to a single solution.

SleepScore Labs, the company behind the world’s most comprehensive suite of science and data-backed sleep solutions, officially appointed Gil Adato as Chief Operating Officer.

RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced that it will host a conference call to discuss its third quarter 2019 financial results on Tuesday, November 12th, 2019 at 7:30 a.m. Pacific Time.

Rising Medical Solutions executive, Rachel Fikes, has assumed a new, elevated position with the company as it looks to create further value for its two primary constituencies – its customers and its employee shareholders.

NanoString Technologies, Inc., a leading provider of life science tools for translational research and molecular diagnostic products, announced the appointment of Don Kania, Ph.D.